Gam Holding Ag Exact Sciences Corp Transaction History

Gam Holding Ag

11 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q1 2022 May 06, 2022	SELL	$57.56 - $82.54 $57 - $82	-1 Reduced 0.01%	7,062 $494,000
Q3 2021 Nov 12, 2021	BUY	$90.24 - $124.05 $90 - $124	1 Added 0.01%	7,063 $674,000
Q2 2021 Aug 09, 2021	SELL	$93.66 - $139.27 $93 - $139	-1 Reduced 0.01%	7,062 $878,000
Q1 2021 May 10, 2021	BUY	$116.57 - $155.01 $823,333 - $1.09 Million	7,063 New	7,063 $931,000
Q4 2020 Feb 10, 2021	SELL	$99.61 - $142.12 $4.83 Million - $6.89 Million	-48,505 Closed	0 $0
Q3 2020 Nov 06, 2020	BUY	$72.92 - $102.01 $729 - $1,020	10 Added 0.02%	48,505 $4.95 Million
Q2 2020 Aug 10, 2020	SELL	$55.75 - $92.75 $613 - $1,020	-11 Reduced 0.02%	48,495 $4.22 Million
Q1 2020 May 12, 2020	BUY	$37.9 - $104.44 $367,819 - $1.01 Million	9,705 Added 25.01%	48,506 $2.81 Million
Q4 2019 Feb 06, 2020	BUY	$77.66 - $99.74 $487,704 - $626,367	6,280 Added 19.31%	38,801 $3.59 Million
Q3 2019 Nov 08, 2019	BUY	$90.37 - $122.49 $74,645 - $101,176	826 Added 2.61%	32,521 $2.94 Million
Q1 2019 May 10, 2019	BUY	$61.98 - $96.5 $1.96 Million - $3.06 Million	31,695 New	31,695 $2.75 Million

673

162M

2.58M

2.19M

Ticker EXAS
Exchange NASDAQ
Sector Healthcare
Industry Diagnostics & Research
Shares Outstandng 176,960,000
Market Cap $10.2B
Description
Exact Sciences Corporation provides cancer screening and diagnostic test products in the United States and internationally. The company offers Cologuard, a non-invasive stool-based DNA screening test to detect DNA and hemoglobin biomarkers associated with colorectal cancer and pre-cancer. It also provides Oncotype DX, a gene expression tests for...

Get notified when there are updates to the investment portfolio of Gam Holding Ag, based on Form 13F filings with the SEC.

Stay updated on Gam Holding Ag with notifications on news.